Journal
New England Journal of Medicine
Publication Date
6-8-2023
Volume
388
Issue
23
First Page
2159
Last Page
2170
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2302312
Rights and Permissions
Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS, Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA 3rd, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer. N Engl J Med. 2023 Jun 8;388(23):2159-2170. doi: 10.1056/NEJMoa2302312. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Eskander, Ramez N; Thaker, Premal H; Powell, Matthew A; and et al., "Pembrolizumab plus chemotherapy in advanced endometrial cancer." New England Journal of Medicine. 388, 23. 2159 - 2170. (2023).
https://digitalcommons.wustl.edu/oa_4/2335
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
